EU To Join Countries Covered By India’s Clinical Investigation Waiver Rule
Indian regulators intend to waive their clinical investigation requirements for certain medical devices that are already approved in the EU.
You may also be interested in...
Now that the European Medicines Agency has finalized its formal safety review procedure into Xeljanz, Pfizer is telling health care professionals what precautions they must take when prescribing the drug.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.